The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
BSAC standardized disc susceptibility testing method (version 7)
Open accessAbstract
The changes that have been made to the previous version of the recommendations (version 6) are as follows: medium and incubation condition for testing Acinetobacter spp. (Tables 1 and 6); use of cefoxitin as an indicator antibiotic for detecting methicillin/oxacillin/cefoxitin resistance in coagulase-negative staphylococci (Tables 1, 6 and 11); MIC breakpoint for co-trimoxazole based on the trimethoprim concentration in a 1:19 combination with sulfamethoxazole (Tables 7, 10, 11, 12, 15, 16 and 19); advice on the use of azithromycin for the treatment of infections with Salmonella typhi (footnote to Table 7); amendment to the recommendation for cefuroxime for the treatment of infections with Proteus mirabilis (footnote Table 7); MIC and zone diameter breakpoints for Stenotrophomonas maltophilia only (Table 10); MIC breakpoints for daptomycin (Tables 11 and 15); clarification for staphylococci that the neomycin zone diameter breakpoints are for topical use only and differentiate the isolates outside the 'wild-type' population in Table 11; clarification for beta-haemolytic streptococci that the linezolid zone diameter breakpoints relate to an MIC breakpoint of 2 mg/L as no data for the intermediate category are currently available (Table 15); clarification that strains with reduced susceptibility to fluoroquinolones give no zone of inhibition with a 30 microg nalidixic acid disc (Tables 16 and 21); erythromycin is no longer used for therapy of Neisseria gonorrhoeae, but may be tested for epidemiological purposes (Table 17); clarification that the ciprofloxacin zone diameter breakpoint for Neisseria meningitidis relates to the MIC breakpoint of 0.03 mg/L as no data for the intermediate category are currently available; clarification that the ciprofloxacin zone diameter breakpoints for Campylobacter spp. relate to an MIC breakpoint of 0.5 mg/L as no data for the intermediate category are currently available; clarification that for ciprofloxacin and vancomycin zone diameter breakpoints for coryneform organisms relate to an MIC breakpoint of 0.5 and 4 mg/L, respectively, as no data for the intermediate category are currently available; MIC and zone diameter breakpoints for Gram-negative rods isolated from urinary tract infections have been expanded to include Klebsiella spp.; and a definition of coliforms is also included (Table 26).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibiotics in Laboratory Medicine.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-4-653_4 · Cited by 2,779
Gould, F. K., Denning, D. W., Elliott, T. S. J., Foweraker, J., Perry, J. D., Prendergast, B. D., Sandoe, J. A. T., Spry, M. J., & Watkin, R. W. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr450 · Cited by 593
Wistrom, J. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.1.43 · Cited by 448
European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria
Kahlmeter, G. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg312 · Cited by 397
BSAC standardized disc susceptibility testing method
Testing, F. T. B. W. P. O. S., & Andrews, J. M. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.suppl_1.43 · Cited by 335
Self-citationRisk Factors for Persistent Carriage of Methicillin‐Resistant Staphylococcus aureus
Harbarth, S., Liassine, N., Dharan, S., Herrault, P., Auckenthaler, R., & Pittet, D. (2000) · Clinical Infectious Diseases · doi:10.1086/317484 · Cited by 197
Elliott, T., Foweraker, J. E., Gould, F. K., Perry, J. D., & Sandoe, J. A. T. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh474 · Cited by 149
Detection of methicillin/oxacillin resistance in staphylococci
Brown, D. F. J. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.suppl_1.65 · Cited by 138
BSAC standardized disc susceptibility testing method (version 6)
Andrews, J. M. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm110 · Cited by 92
Self-citationThe development of the BSAC standardized method of disc diffusion testing
Andrews, J. M. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.suppl_1.29 · Cited by 83
Self-citation
Cited by
Rizzo, L., Manaia, C., Merlin, C., Schwartz, T., Dagot, C., Ploy, M. C., Michael, I., & Fatta-Kassinos, D. (2013) · Science of The Total Environment · doi:10.1016/j.scitotenv.2013.01.032 · Cited by 2,493
García-Álvarez, L., Holden, M. T., Lindsay, H., Webb, C. R., Brown, D. F., Curran, M. D., Walpole, E., Brooks, K., Pickard, D. J., Teale, C., et al. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70126-8 · Cited by 939
Matuschek, E., Brown, D. F. J., & Kahlmeter, G. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12373 · Cited by 887
The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii
Turton, J. F., Ward, M. E., Woodford, N., Kaufmann, M. E., Pike, R., Livermore, D. M., & Pitt, T. L. (2006) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2006.00195.x · Cited by 751
Winstanley, C., O’Brien, S., & Brockhurst, M. A. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2016.01.008 · Cited by 689
Miller, E., Andrews, N. J., Waight, P. A., Slack, M. P., & George, R. C. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70090-1 · Cited by 643
Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria
Li, J., Nation, R. L., Milne, R. W., Turnidge, J. D., & Coulthard, K. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.10.001 · Cited by 571
Bradley, P., Gordon, N. C., Walker, T. M., Dunn, L., Heys, S., Huang, B., Earle, S., Pankhurst, L. J., Anson, L., de Cesare, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms10063 · Cited by 556
Stenotrophomonas maltophilia: an emerging opportunist human pathogen
Looney, W. J., Narita, M., & Mühlemann, K. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70083-0 · Cited by 550
Woodford, N., Ward, M. E., Kaufmann, M. E., Turton, J., Fagan, E. J., James, D., Johnson, A. P., Pike, R., Warner, M., Cheasty, T., et al. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh424 · Cited by 472
Seemungal, T. A. R., Wilkinson, T. M. A., Hurst, J. R., Perera, W. R., Sapsford, R. J., & Wedzicha, J. A. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200801-145oc · Cited by 444
Editorial: Assessing the antimicrobial susceptibility of bacteria obtained from animals
Schwarz, S., Silley, P., Simjee, S., Woodford, N., van Duijkeren, E., Johnson, A. P., & Gaastra, W. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq037 · Cited by 442
Brown, D. F. J., Edwards, D. I., Hawkey, P. M., Morrison, D., Ridgway, G. L., Towner, K. J., & Wren, M. W. D. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki372 · Cited by 410
Beceiro, A., Llobet, E., Aranda, J., Bengoechea, J. A., Doumith, M., Hornsey, M., Dhanji, H., Chart, H., Bou, G., Livermore, D. M., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00079-11 · Cited by 379
Role of copper in reducing hospital environment contamination
Casey, A. L., Adams, D., Karpanen, T. J., Lambert, P. A., Cookson, B. D., Nightingale, P., Miruszenko, L., Shillam, R., Christian, P., & Elliott, T. S. J. (2010) · Journal of Hospital Infection · doi:10.1016/j.jhin.2009.08.018 · Cited by 355
Prediction of Staphylococcus aureus Antimicrobial Resistance by Whole-Genome Sequencing
Gordon, N. C., Price, J. R., Cole, K., Everitt, R., Morgan, M., Finney, J., Kearns, A. M., Pichon, B., Young, B., Wilson, D. J., et al. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.03117-13 · Cited by 339
Disinfectants and antiseptics: mechanisms of action and resistance
Maillard, J.-Y., & Pascoe, M. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00958-3 · Cited by 282
Transfer of antibiotic resistance by transformation with eDNA within oral biofilms
Hannan, S., Ready, D., Jasni, A. S., Rogers, M., Pratten, J., & Roberts, A. P. (2010) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2010.00661.x · Cited by 125
Wedley, A. L., Dawson, S., Maddox, T. W., Coyne, K. P., Pinchbeck, G. L., Clegg, P., Nuttall, T., Kirchner, M., & Williams, N. J. (2017) · Veterinary Microbiology · doi:10.1016/j.vetmic.2016.11.017 · Cited by 91
Schmidt, V. M., Pinchbeck, G. L., Nuttall, T., McEwan, N., Dawson, S., & Williams, N. J. (2015) · Preventive Veterinary Medicine · doi:10.1016/j.prevetmed.2015.01.013 · Cited by 67
Klopper, K. B., Deane, S. M., & Dicks, L. M. T. (2018) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-017-9307-5 · Cited by 53
Weerdenburg, E., Davies, T., Morrow, B., Zomer, A. L., Hermans, P., Go, O., Spiessens, B., van den Hoven, T., van Geet, G., Aitabi, M., et al. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciac421 · Cited by 49
Metadata
- Authors
- Andrews, J. M., & Testing, F. T. B. W. P. O. S.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-01-31
- Volume
- 62
- Issue
- 2
- Pages
- 256-278
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2161568532
- Cited by
- 734
- References
- 14
- FWCI
- 35.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.